EUVIMEDEUVIMED entdecken
Open Access

Disseminated Mycobacterium bovis ‐BCG Infection Following Intravesical BCG Administration in Solid Organ Transplant Recipients

Paavana Varanasi, Nancy Wengenack, D Eric Steidley, Lavanya Kodali iD, Holenarasipur R Vikram iD

Transplant Infectious Disease · 2026-07 · 28 (4)

DOI: 10.1111/tid.70220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, online erschienen am 21.04.2026. Verfasst von Paavana Varanasi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Transplant Center, Mayo Clinic, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: BCG Vaccine, Mycobacterium bovis, Organ Transplantation, Tuberculosis. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intravesical Bacillus Calmette–Guerin (BCG) is a live attenuated vaccine for tuberculosis. Intravesical BCG (iBCG) administration is a highly effective immunotherapy for non‐muscle invasive bladder cancer (NMIBC). Although live attenuated vaccines are generally contraindicated in solid organ transplant recipients (SOTR), iBCG has been utilized for NMIBC in SOTR. We describe the clinical manifestations, management, and outcomes of disseminated Mycobacterium bovis ‐BCG infection (Mb‐BCGi) following iBCG therapy in SOTR for NMIBC.

Methods

All adult patients (> 18 years of age) diagnosed with NMIBC who received iBCG across three tertiary referral and transplant centers between 2000 and 2025 were identified. The study cohort consisted of SOTR who had received iBCG for NMIBC and subsequently developed disseminated Mb‐BCGi. English language literature review was performed to identify additional cases.

Results

A total of 4207 patients received iBCG during the study period. Thirty (0.71%) were SOTR, of whom two (6.7%) developed disseminated Mb‐BCGi, including bloodstream infection and prostate abscesses. Literature review identified two additional disseminated Mb‐BCGi cases in SOTR with lungs, bloodstream, and native kidney involvement, and one fatality. All cases required extended antimycobacterial therapy. Median times from SOT to Mb‐BCGi and from iBCG to Mb‐BCGi were 104 and 8 months, respectively.

Conclusion

SOTR appear to be at a higher risk of disseminated Mb‐BCGi following iBCG. Administration of iBCG in SOTR with NMIBC warrants careful risk‐benefit assessment and subsequent close monitoring. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BCG VaccineMycobacterium bovisOrgan TransplantationTuberculosisHumansMaleAdministration, IntravesicalNon-Muscle Invasive Bladder NeoplasmsFemaleMiddle AgedAgedTransplant RecipientsAdultRetrospective StudiesUrinary Bladder Neoplasms

Stichwörter der Autor:innen

BCGBCGosisMycobacterium bovisdisseminatedmycobacteriatransplant

Substanzen

BCG Vaccine

Autor:innen und Institutionen

  • Transplant Center, Mayo Clinic, Phoenix, Arizona, USA.
  • Division of Nephrology & Transplant Nephrology, Mayo Clinic, Phoenix, Arizona, USA.
  • Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Advanced Heart Failure & Transplant, Mayo Clinic, Phoenix, Arizona, USA.
  • Division of Infectious Diseases, Mayo Clinic, Phoenix, Arizona, USA.

ORCID-Profile: Lavanya Kodali, Holenarasipur R Vikram

Zitieren

APA

Varanasi, P., Wengenack, N., Steidley, D. E., Kodali, L., & Vikram, H. R. (2026). Disseminated Mycobacterium bovis ‐BCG Infection Following Intravesical BCG Administration in Solid Organ Transplant Recipients. Transplant Infectious Disease, 28(4). https://doi.org/10.1111/tid.70220

Vancouver

Varanasi P, Wengenack N, Steidley DE, Kodali L, Vikram HR. Disseminated Mycobacterium bovis ‐BCG Infection Following Intravesical BCG Administration in Solid Organ Transplant Recipients. Transplant Infectious Disease. 2026;28(4). doi:10.1111/tid.70220

BibTeX
@article{Varanasi2026,
  author = {Varanasi, Paavana and Wengenack, Nancy and Steidley, D Eric and Kodali, Lavanya and Vikram, Holenarasipur R},
  title = {Disseminated Mycobacterium bovis ‐BCG Infection Following Intravesical BCG Administration in Solid Organ Transplant Recipients},
  journal = {Transplant Infectious Disease},
  year = {2026},
  volume = {28},
  number = {4},
  doi = {10.1111/tid.70220}
}
Kostenlos starten →